Facebook
Twitter
LinkedIn
ForwardTitle
Category
Credits
Event date
Cost
- Advanced Practice Provider
- 1.00 Participation
$0.00
This lecture will provide information to identify current and future cancer survivorship trends, use a framework to analyze survivors’ risks for long-term late effects and identify unmet needs, describe the APPs role in delivering follow-up/survivorship care and list survivorship resources.
- Advanced Practice Provider
- 1.00 Participation
$0.00
Exploration of diet related factors that may affect patient response to anti-cancer immunotherapy.
- Advanced Practice Provider
- 1.00 NCPD/CNE
- 1.00 Participation
$0.00
Patients with cancer who have minor-age children at home face unique psychosocial challenges in coping with impact of their diagnosis, treatment, and prognosis. A parental cancer diagnosis threatens to disrupt family functioning, re-organize roles and responsibilities in the home, and negatively affect parenting self-efficacy. A parent’s ability to navigate these challenging times can have ramifications for years to come. The current webinar will provide an overview of the extent research in this field, offer strategies that providers can use to enhance the coping of parents with cancer, and describe a new clinic at UNC designed specifically to address the challenges facing this subset of the cancer population.
- Advanced Practice Provider
- 1.00 NCPD/CNE
- 1.00 Participation
$0.00
Clarissa Urban, PA-C, will cover the basics of clinical trials for an APP. She will highlight the different phases of trials, the clinical trial team, and documents pertaining to trials. In addition, she will focus on phase 1 clinical trials along with diversity in trial participation.
- Advanced Practice Provider
- 1.00 NCPD/CNE
- 1.00 Participation
$0.00
Attendees will learn about the benefits of exercise during and after cancer treatment, designing programs that provide maximum benefits, and how to engage patients in increasing their physical activity during and after treatment.
- Advanced Practice Provider
- 1.00 NCPD/CNE
- 1.00 Participation
$0.00
Robyn Tolley, AGPCNP-BC, will identify cytotoxic vesicant and irritant drugs, evaluation of infiltration and extravasation, recommended non-pharmacologic and pharmacologic treatments, and when care should be advanced to involve plastic surgery. She will also include an evaluation of risk factors and appropriate preventive measures to reduce the risk of extravasation.
- Advanced Practice Provider
- 1.00 NCPD/CNE
- 1.00 Participation
$0.00
Allison Phillips, MPAP, MHPE, PA-C, reviews the clinical manifestations, underlying causes, and management of some of the most common emergencies facing patients undergoing cancer treatment, including Superior Vena Cava Syndrome, Hypercalcemia, and SIADH.
- Advanced Practice Provider
- 1.00 NCPD/CNE
- 1.00 Participation
$0.00
This multidisciplinary Panel Presentation will describe the importance of CT-based lung cancer screening, indications and criteria for screening, the optimal structure and requirements of a screening program, and the current state of screening at UNC. We will present practical information relevant to providers who may order screening CT and/or may discuss screening with patients.
- Advanced Practice Provider
- 1.00 NCPD/CNE
- 1.00 Participation
$0.00
Jeremiah 'Jig' Deneve, DO, FACS, provides an overview of the natural history, treatment, and outcome for peritoneal carcinomatosis.
- Advanced Practice Provider
- 1.00 NCPD/CNE
- 1.00 Participation
$0.00
Patients undergoing treatment for cancer utilize many medications that have relevant drug-gene interactions. The use of pharmacogenomic testing can assist with drug selection, drug dosing, and the development of personalized medication monitoring plans. Amber Cipriani, PharmD, BCOP, will describe some common examples of drug-gene interactions relevant to oncology. She will also discuss current efforts to expand the use of pharmacogenomic testing into current clinical practice.